← FDA Drug Approvals (Drugs@FDA)

PALBOCICLIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA LIMITED · Approved 2026-07-13

Drug application

FDA Application #

ANDA220120

Application type

Abbreviated New Drug Application (Generic)

Brand name

PALBOCICLIB

Generic name

Palbociclib

Active ingredients

PALBOCICLIB

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

BIOCON PHARMA LIMITED

First approval

2026-07-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown